{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:33:12Z","timestamp":1793053992414,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.eprac.2025.10.011","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:51:34Z","timestamp":1761493894000},"page":"1642-1648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Menopause Hormone Therapy: 30 Years of Advances and Controversies"],"prefix":"10.1016","volume":"31","author":[{"given":"Arielle M.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ellen","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8011-7094","authenticated-orcid":false,"given":"Gina P.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2025.10.011_bib1","series-title":"StatPearls [Internet]","article-title":"Menopause (nursing)","author":"Peacock","year":"2025"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.011_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4158\/EP.1.1.27","article-title":"Estrogen replacement therapy in osteoporosis: advances and controversies","volume":"1","author":"Pacifici","year":"1995","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.eprac.2025.10.011_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/oxfordjournals.aje.a112149","article-title":"Characteristics of menopausal women: a survey of King and Pierce counties in Washington, 1973-2974","volume":"102","author":"Stadel","year":"1975","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.011_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: annual trends and response to recent evidence","volume":"291","author":"Hersh","year":"2004","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.eprac.2025.10.011_bib5","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM198510243131703","article-title":"A prospective study of postmenopausal estrogen therapy and coronary heart disease","volume":"313","author":"Stampfer","year":"1985","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.eprac.2025.10.011_bib6","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199706193362501","article-title":"Postmenopausal hormone therapy and mortality","volume":"336","author":"Grodstein","year":"1997","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.eprac.2025.10.011_bib7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.CIR.75.6.1102","article-title":"Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study","volume":"75","author":"Bush","year":"1987","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.eprac.2025.10.011_bib8","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/0002-8703(88)90063-4","article-title":"Postmenopausal use of estrogen and occlusion of coronary arteries","volume":"115","author":"Gruchow","year":"1988","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.eprac.2025.10.011_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-108-3-358","article-title":"Postmenopausal estrogen use and coronary atherosclerosis","volume":"108","author":"Sullivan","year":"1988","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.011_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00042192-200512010-00009","article-title":"Hormone therapy and coronary artery calcification in asymptomatic postmenopausal women: the Rancho Bernardo Study","volume":"12","author":"Barrett-Connor","year":"2005","journal-title":"Menopause"},{"issue":"17","key":"10.1016\/j.eprac.2025.10.011_bib11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM198510243131702","article-title":"Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study","volume":"313","author":"Wilson","year":"1985","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.eprac.2025.10.011_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen\/progestin replacement study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.eprac.2025.10.011_bib13","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.eprac.2025.10.011_bib14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women\u2019s Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.eprac.2025.10.011_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/GME.0000000000000343","article-title":"Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis","volume":"22","author":"Hodis","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.eprac.2025.10.011_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e6409","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial","volume":"345","author":"Schierbeck","year":"2012","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.eprac.2025.10.011_bib17","article-title":"Hormone therapy for preventing cardiovascular disease in post-menopausal women","volume":"2015","author":"Boardman","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.eprac.2025.10.011_bib18","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the Esther study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"issue":"9382","key":"10.1016\/j.eprac.2025.10.011_bib19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.eprac.2025.10.011_bib20","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00404-022-06647-5","article-title":"Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review","volume":"307","author":"Gold\u0161tajn","year":"2023","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"10.1016\/j.eprac.2025.10.011_bib21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/gme.0b013e31824c8a5a","article-title":"Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts","volume":"19","author":"Kaunitz","year":"2012","journal-title":"Menopause"},{"issue":"25","key":"10.1016\/j.eprac.2025.10.011_bib22","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1161\/CIR.0000000000000912","article-title":"Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association","volume":"142","author":"El Khoudary","year":"2020","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.eprac.2025.10.011_bib23","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.eprac.2025.10.011_bib24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/GME.0000000000000899","article-title":"Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women\u2019s Health Initiative Observational Study","volume":"24","author":"Crandall","year":"2017","journal-title":"Menopause"},{"issue":"11","key":"10.1016\/j.eprac.2025.10.011_bib25","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.amjcard.2008.01.043","article-title":"Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events","volume":"101","author":"Bray","year":"2008","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.eprac.2025.10.011_bib26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","article-title":"Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women","volume":"8","author":"Salpeter","year":"2006","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1016\/j.eprac.2025.10.011_bib27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/GME.0000000000000492","article-title":"The North American Menopause Society statement on continuing use of systemic hormone therapy after age 65","volume":"22","year":"2015","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.eprac.2025.10.011_bib28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMcp1714787","article-title":"Hormone therapy for postmenopausal women","volume":"382","author":"Pinkerton","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eprac.2025.10.011_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/20420188211013917","article-title":"Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use","volume":"12","author":"Prabakaran","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2025.10.011_bib30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.122.061559","article-title":"Rethinking menopausal hormone therapy: for whom, what, when, and how long?","volume":"147","author":"Cho","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.eprac.2025.10.011_bib31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/GME.0000000000001463","article-title":"Systemic estradiol levels with low-dose vaginal estrogens","volume":"27","author":"Santen","year":"2020","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.eprac.2025.10.011_bib32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/GME.0000000000001284","article-title":"Vaginal estrogen use and chronic disease risk in the Nurses\u2019 Health Study","volume":"26","author":"Bhupathiraju","year":"2018","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.011_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GME.0000000000000956","article-title":"Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women\u2019s Health Initiative Observational Study","volume":"25","author":"Crandall","year":"2018","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.eprac.2025.10.011_bib34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/gme.0b013e3181a7fb1e","article-title":"The effects of Bazedoxifene on mammographic breast density in postmenopausal women with osteoporosis","volume":"16","author":"Harvey","year":"2009","journal-title":"Menopause"},{"issue":"10","key":"10.1016\/j.eprac.2025.10.011_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1940-6207.CAPR-19-0315","article-title":"Effect of Bazedoxifene and conjugated estrogen (Duavee) on breast cancer risk biomarkers in high-risk women: a pilot study","volume":"12","author":"Fabian","year":"2019","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"10.1016\/j.eprac.2025.10.011_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/GME.0000000000000550","article-title":"Hormone therapy and risk of ovarian cancer in postmenopausal women: a systematic review and meta-analysis","volume":"23","author":"Shi","year":"2016","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.eprac.2025.10.011_bib37","first-page":"767","article-title":"\u201cThe 2022 Hormone Therapy Position Statement of The North American Menopause Society\u201d Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society","volume":"29","year":"2022","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.eprac.2025.10.011_bib38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/GME.0000000000002200","article-title":"The 2023 nonhormone therapy position statement of the North American Menopause Society","volume":"30","year":"2023","journal-title":"Menopause"},{"issue":"24","key":"10.1016\/j.eprac.2025.10.011_bib39","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.2019.19191","article-title":"Association of premature natural and surgical menopause with incident cardiovascular disease","volume":"322","author":"Honigberg","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.011_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.AOG.0000441353.20693.78","article-title":"ACOG Practice Bulletin No. 141: management of menopausal symptoms","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.eprac.2025.10.011_bib41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Duration of menopausal vasomotor symptoms over the menopause transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.eprac.2025.10.011_bib42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/GME.0000000000002335","article-title":"Use of menopausal hormone therapy beyond age 65 years and its effects on women\u2019s health outcomes by types, routes, and doses","volume":"31","author":"Baik","year":"2024","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.eprac.2025.10.011_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12986-024-00858-0","article-title":"The association between age of menopause and type 2 diabetes: a systematic review and meta-analysis","volume":"21","author":"Yazdkhasti","year":"2024","journal-title":"Nutr Metab (Lond)"},{"issue":"4","key":"10.1016\/j.eprac.2025.10.011_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2024.101546","article-title":"Menopausal hormone therapy decreases the likelihood of diabetes development in peri-menopausal individuals with prediabetes","volume":"50","author":"Shih","year":"2024","journal-title":"Diabetes Metab"},{"issue":"suppl 1","key":"10.1016\/j.eprac.2025.10.011_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American Association of Clinical Endocrinologists\/American College of Endocrinology Clinical Practice guidelines for the diagnosis and treatment of postmenopausal Osteoporosis-2020 update","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.eprac.2025.10.011_bib46","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa048","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society guideline update","volume":"105","author":"Shoback","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2025.10.011_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2025.100729","article-title":"Discontinuation of menopausal hormone therapy and risk of fracture: nested case-control studies using routinely collected primary care data","volume":"6","author":"Vinogradova","year":"2025","journal-title":"Lancet Healthy Longev"},{"issue":"8","key":"10.1016\/j.eprac.2025.10.011_bib48","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/GME.0000000000000419","article-title":"A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of Bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture","volume":"22","author":"Palacios","year":"2015","journal-title":"Menopause"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25012595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25012595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:36:52Z","timestamp":1765967812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25012595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1530891X25012595"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.10.011","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menopause Hormone Therapy: 30 Years of Advances and Controversies","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}